Evidence map›Paper›PMID 21256959›Full record

ArticleFree radical biology & medicine2011

Effect of nitric oxide on neointimal hyperplasia based on sex and hormone status.

Melissa E Hogg, Vinit N Varu, Ashley K Vavra, Daniel A Popowich, Monisha N Banerjee, Janet Martinez, Qun Jiang, Joseph E Saavedra, Larry K Keefer, Melina R Kibbe

Abstract read
In one paragraph

Article in Free radical biology & medicine, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Melissa E HoggDivision of Vascular Surgery and the Institute for BioNanotechnology in Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA.
Vinit N Varu
Ashley K Vavra
Daniel A Popowich
Monisha N Banerjee
Janet Martinez
Qun Jiang
Joseph E Saavedra
Larry K Keefer
Melina R Kibbe
Northwestern University · USNational Cancer Institute · USScience Applications International Corporation (United States) · US

Funding

MULTIDISCIPLINARY CLINICAL AND TRANSLATIONAL SCIENCE (MCTS) PROGRAM (UL1)UL1RR025741 · NCRR · NORTHWESTERN UNIVERSITY AT CHICAGO · PI GREENLAND, PHILIP · 2008 to 2011
$24.7M
Using Diazeniumdiolate Chemistry to Design Nitric Oxide-Based TherapiesZIABC005673 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI KEEFER, LARRY K · 2009 to 2015
$5.5M
Nitric oxide eluting therapies for vascular surgeryK08HL084203 · NHLBI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI KIBBE, MELINA RAE · 2006 to 2010
$633k
NCI NIH HHS N01 CO012400NCI NIH HHS N01-CO-12400NCRR NIH HHS UL1 RR025741NHLBI NIH HHS K08 HL084203NHLBI NIH HHS K08HL084203
6 · The paper itself

Abstract

Nitric oxide (NO)-based therapies decrease neointimal hyperplasia; however, studies have been performed only in male animal models. Thus, we sought to evaluate the effect of NO on vascular smooth muscle cells (VSMC) in vitro and neointimal hyperplasia in vivo based on sex and hormone status. In hormone-replete medium, male VSMC proliferated at greater rates than female VSMC. In hormone-depleted medium, female VSMC proliferated at greater rates than male VSMC. However, in both hormone environments, NO inhibited proliferation and migration to a greater extent in male compared to female VSMC. These findings correlated with greater G₀/G₁ cell cycle arrest and changes in cell cycle protein expression in male compared to female VSMC after exposure to NO. Next, the rat carotid artery injury model was used to assess the effect of NO on neointimal hyperplasia in vivo. Consistent with the in vitro data, NO was significantly more effective at inhibiting neointimal hyperplasia in hormonally intact males compared to females using weight-based dosing. An increased weight-based dose of NO in females was able to achieve efficacy equal to that in males. Surprisingly, NO was less effective at inhibiting neointimal hyperplasia in castrated animals of both sexes. In conclusion, these data suggest that NO inhibits neointimal hyperplasia more effectively in males compared to females and in hormonally intact compared to castrated rats, indicating that the effects of NO in the vasculature may be sex- and hormone-dependent.

Indexed as

AnimalsAortaAzo CompoundsCarotid Artery InjuriesCastrationCell Culture TechniquesCell CycleCell Cycle ProteinsCell MovementCell ProliferationCells, CulturedFemaleHormonesHyperplasiaMaleMuscle, Smooth, VascularAzo CompoundsCell Cycle ProteinsdiazeniumdiolateHormonesNitric OxideNitric Oxide Donors

Identifiers

PMID21256959
PMCPMC3070831
OpenAlexW2053803045

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.